ABBOT STEWART
Insider CIK 1655597 · FATE Chief Development Officer · ACET See Remarks · TSBX Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TSBX Turnstone Biologics Corp. | A Award deriv | 2023-10-16 | 2023-10-17 | 45,542 | — | $0 | 45,542 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-06-11 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-02-12 | 2021-02-17 | 106,900 | — | $0 | 106,900 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-01-13 | 2021-01-15 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 63,751 | — | $0 | 63,751 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 57,151 | — | $0 | 57,151 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 84,791 | — | $0 | 84,791 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2018-05-15 | 2018-05-16 | 2,916 | — | $0 | 67,084 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2018-05-15 | 2018-05-16 | 18,138 | — | $0 | 51,862 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2018-05-15 | 2018-05-16 | 18,138 | $6.90 | $125.2K | 64,917 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2018-05-15 | 2018-05-16 | 2,916 | $4.89 | $14.3K | 46,779 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2018-01-16 | 2018-01-17 | 186,000 | — | $0 | 186,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2017-01-04 | 2017-01-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2016-01-08 | 2016-01-12 | 148,800 | — | $0 | 148,800 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2016-01-08 | 2016-01-12 | 3,863 | — | $0 | 43,863 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-10-15 | 2015-10-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2015-10-15 | 2015-10-16 | 40,000 | — | $0 | 40,000 | SEC↗ |